| Description: |
This TVMV protease expression
vector is intended to be used for controlled intracellular processing of fusion
proteins (TVMV protease substrates) in E. coli. |
| |
|
| Origin: |
A pZ derivative (Lutz and
Bujard, 1997) |
| |
|
| Replicon: |
p15A |
| |
|
| Antibotic
Resistance: |
Kanamycin |
| |
|
| Promotor: |
Synthetic
λPL/tetO |
| |
|
| Inducer: |
anhydrotetracycline (100
µg/liter) |
| |
|
| Notes: |
Expression of the TVMV
protease gene on pRK1037 will be constitutive unless the host strain produces
Tet repressor. Regulated expression can be achieved in DH5alphaPro or
BL21Pro cells (Clontech). The specificity of TVMV protease is distinct
from that of TEV protease. The canonical recognition site for TVMV protease is
ETVRFQS, with cleavage occurring between Q and S. The TVMV protease open
reading frame on pRK1037 was constructed from synthetic oligonucleotides and
has been codon-optimized for expression in E. coli. For best results,
perform intracellular processing experiments at 30 °C. |
| |
|
| Literature
Citations: |
Lutz, R. and Bujard, H.
(1997). Independent and tight regulation of transcriptional units in
Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory
elements. Nucl. Acids Res. 25: 1203-10; Yoon, H. Y., Hwang, D. C., Choi,
K. Y., and Song, B. D. (2000). Proteolytic processing of oligopeptides
containing the target sequences by the recombinant tobacco vein mottling virus
NIa protease. Mol. Cells 10: 213-219. |
| |
|
| Nucleotide
Sequence: |
 |
| |
|
| |
|